V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10454291 | 10034459 | null | 76.8 | Curative (C) | 2020-03-11 | 2020-04-02 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE | 101145035 |
| 10454295 | 10034460 | 1.73 | 71.6 | 03 | 2015-11-13 | 2015-11-27 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100264471 |
| 10454317 | 10034461 | 1.7 | 47.4 | Palliative (P) | 2016-10-08 | 2016-10-15 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101218262 |
| 10454352 | 10034462 | 1.58 | 72 | 03 | 2017-10-23 | 2017-10-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100978044 |
| 10454353 | 10034463 | 1.69 | 75 | 03 | 2016-09-30 | 2016-10-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101786418 |
| 10454358 | 10034464 | 1.74 | 71.1 | null | 2018-08-29 | 2018-09-25 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101563581 |
| 10454370 | 10034465 | null | 64.2 | Palliative (P) | 2017-01-14 | 2017-02-28 | IBRUTINIB | 2 | N | IBRUTINIB | 101300021 |
| 10454371 | 10034466 | 1.67 | 98.5 | Palliative (P) | 2015-05-18 | 2018-01-19 | Rituximab | 02 | N | RITUXIMAB | 101686239 |
| 10454404 | 10034467 | 1.67 | 90.4 | Neo-adjuvant (N) | 2020-05-01 | 2020-05-18 | Capecitabine | 02 | N | CAPECITABINE | 101138452 |
| 10454435 | 10034468 | 1.76 | 78 | null | 2017-12-02 | 2017-12-23 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100300749 |
| 10454444 | 10034469 | 1.73 | 68.6 | Palliative (P) | 2018-06-23 | 2018-07-27 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101542436 |
| 10454476 | 10034470 | 1.6 | 68.4 | Palliative (P) | 2019-12-08 | 2019-12-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100962647 |
| 10454499 | 10034471 | null | 97 | Curative (C) | 2020-11-04 | 2020-11-04 | Capecitabine + Oxaliplatin 21day | 99 | null | RITUXIMAB | 100730725 |
| 10454512 | 10034472 | 0 | 43.7 | null | 2022-02-07 | 2022-02-28 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 100741098 |
| 10454520 | 10034473 | 1.79 | 76.2 | null | 2021-12-31 | 2022-01-13 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100414693 |
| 10454528 | 10034474 | 1.86 | 76.95 | null | 2022-02-01 | 2022-02-01 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 100865933 |
| 10454536 | 10034475 | 1.63 | 77.4 | Curative (C) | 2018-08-09 | 2019-02-05 | Rituximab | 02 | N | RITUXIMAB | 100097352 |
| 10454551 | 10034476 | 1.7 | null | Adjuvant (A) | 2018-11-19 | 2018-12-15 | Capecitabine | 02 | N | CAPECITABINE | 101052498 |
| 10454559 | 10034477 | 1.6 | 68 | null | 2020-05-14 | 2020-05-19 | Rituximab | 02 | null | RITUXIMAB | 101643773 |
| 10454564 | 10034478 | 1.64 | 68 | 03 | null | 2019-11-05 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100311586 |
| 10454570 | 10034479 | 1.75 | 114.8 | Palliative (P) | 2016-10-05 | 2016-10-20 | Capecitabine | 02 | N | CAPECITABINE | 100031893 |
| 10454581 | 10034480 | null | 79.2 | 03 | 2017-06-09 | 2017-07-02 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101849020 |
| 10454584 | 10034481 | 1.78 | 81 | Palliative (P) | 2018-09-27 | 2018-11-08 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100240435 |
| 10454590 | 10034482 | 1.67 | 65.4 | Palliative (P) | 2021-02-21 | 2021-03-20 | Rituximab | 02 | N | RITUXIMAB | 100877207 |
| 10454622 | 10034483 | 1.52 | 75.4 | Palliative (P) | 2021-10-28 | 2021-10-30 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100210332 |
| 10454678 | 10034484 | 1.82 | 70.2 | Disease modification (D) | 2017-05-03 | 2017-05-03 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100503522 |
| 10454683 | 10034485 | 1.77 | 55 | null | 2019-01-14 | 2019-01-17 | CHOP R - 21 days | 99 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101137182 |
| 10454693 | 10034486 | 1.61 | 56.25 | Neo-adjuvant (N) | 2017-12-03 | 2017-12-09 | Rituximab | null | null | RITUXIMAB | 101369298 |
| 10454694 | 10034487 | 1.55 | 76 | Palliative (P) | 2019-08-12 | 2019-08-17 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101250190 |
| 10454757 | 10034488 | null | 86.2 | 03 | 2016-12-11 | 2016-12-13 | IBRUTINIB | 02 | N | IBRUTINIB | 101561348 |
| 10454767 | 10034489 | 1.61 | 56 | 03 | 2017-10-27 | 2017-10-28 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101727268 |
| 10454797 | 10034490 | 1.78 | 64.1 | Neo-adjuvant (N) | 2015-10-08 | 2015-10-16 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101129042 |
| 10454805 | 10034491 | 1.75 | 0 | Curative (C) | 2019-08-12 | 2019-08-16 | IBRUTINIB | 02 | N | IBRUTINIB | 100018382 |
| 10454816 | 10034492 | 1.77 | 0 | null | 2019-01-26 | 2019-01-26 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100888720 |
| 10454855 | 10034494 | 1.63 | 68.75 | null | 2022-02-28 | 2022-03-05 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 100916486 |
| 10454869 | 10034495 | 1.53 | 96 | null | 2018-11-04 | 2018-11-12 | Rituximab | 02 | null | RITUXIMAB | 101606455 |
| 10454876 | 10034496 | 1.64 | 85.4 | Palliative (P) | 2018-04-01 | 2018-04-01 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 100491682 |
| 10454880 | 10034497 | null | 44.9 | Curative (C) | 2019-11-23 | 2019-11-23 | IBRUTINIB | 02 | N | IBRUTINIB | 101441679 |
| 10454887 | 10034498 | 1.8 | 80.6 | null | 2021-05-22 | 2021-05-29 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 101780874 |
| 10454894 | 10034499 | 0 | 60.2 | Palliative (P) | 2020-05-18 | 2020-05-21 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100850509 |
| 10454897 | 10034500 | 1.67 | 71 | Palliative (P) | 2019-11-02 | 2019-11-08 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101494697 |
| 10454947 | 10034502 | 1.7 | 85 | Curative (C) | 2017-01-09 | 2017-01-09 | IBRUTINIB | 02 | N | IBRUTINIB | 101448462 |
| 10454954 | 10034503 | 1.49 | 99.95 | Neo-adjuvant (N) | 2015-12-29 | 2016-01-05 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 100153826 |
| 10454957 | 10034504 | 1.67 | 73.3 | Palliative (P) | 2020-01-16 | 2020-01-21 | CHOP R | 2 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100979708 |
| 10454966 | 10034505 | null | 117 | Adjuvant (A) | 2016-12-18 | 2016-12-18 | IBRUTINIB | 02 | N | IBRUTINIB | 101415479 |
| 10454983 | 10034506 | 1.72 | 75.4 | 03 | 2017-10-17 | 2017-10-26 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100640965 |
| 10454999 | 10034507 | 1.75 | 94.5 | Palliative (P) | 2015-09-30 | 2015-10-11 | Rituximab | 02 | N | RITUXIMAB | 101582608 |
| 10455026 | 10034509 | 1.81 | 0 | null | null | 2020-03-20 | Docetaxel | 02 | null | DOCETAXEL | 100435897 |
| 10455043 | 10034510 | null | 58.4 | Curative (C) | 2012-11-13 | 2017-06-24 | IBRUTINIB | 02 | N | IBRUTINIB | 101059613 |
| 10455059 | 10034511 | 1.84 | 99.6 | null | 2022-01-09 | 2022-01-09 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101792696 |